BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35446907)

  • 1. Early cost-effectiveness analysis of screening for preeclampsia in nulliparous women: A modelling approach in European high-income settings.
    Zakiyah N; Tuytten R; Baker PN; Kenny LC; Postma MJ; van Asselt ADI;
    PLoS One; 2022; 17(4):e0267313. PubMed ID: 35446907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
    Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
    Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent pre-term pre-eclampsia in Belgium.
    Dubon Garcia A; Devlieger R; Redekop K; Vandeweyer K; Verlohren S; Poon LC
    Pregnancy Hypertens; 2021 Aug; 25():219-224. PubMed ID: 34271426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation.
    Sharma P; Boyers D; Boachie C; Stewart F; Miedzybrodzka Z; Simpson W; Kilonzo M; McNamee P; Mowatt G
    Health Technol Assess; 2012; 16(17):1-266. PubMed ID: 22469073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeat screening for syphilis in pregnancy as an alternative screening strategy in the UK: a cost-effectiveness analysis.
    Huntington S; Weston G; Seedat F; Marshall J; Bailey H; Tebruegge M; Ahmed I; Turner K; Adams E
    BMJ Open; 2020 Nov; 10(11):e038505. PubMed ID: 33444184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of preventive screening and lifestyle interventions in women with a history of preeclampsia: A micro-simulation study.
    Lagerweij GR; Brouwers L; De Wit GA; Moons K; Benschop L; Maas A; Franx A; Wermer M; Roeters van Lennep JE; van Rijn BB; Koffijberg H
    Eur J Prev Cardiol; 2020 Sep; 27(13):1389-1399. PubMed ID: 32054298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation.
    Stinton C; Jordan M; Fraser H; Auguste P; Court R; Al-Khudairy L; Madan J; Grammatopoulos D; Taylor-Phillips S
    Health Technol Assess; 2021 Jun; 25(42):1-216. PubMed ID: 34169821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
    Fernandes S; Sicuri E; Kayentao K; van Eijk AM; Hill J; Webster J; Were V; Akazili J; Madanitsa M; ter Kuile FO; Hanson K
    Lancet Glob Health; 2015 Mar; 3(3):e143-53. PubMed ID: 25701992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation.
    Farrar D; Simmonds M; Griffin S; Duarte A; Lawlor DA; Sculpher M; Fairley L; Golder S; Tuffnell D; Bland M; Dunne F; Whitelaw D; Wright J; Sheldon TA
    Health Technol Assess; 2016 Nov; 20(86):1-348. PubMed ID: 27917777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preeclampsia Prevention Using Routine Versus Screening Test-Indicated Aspirin in Low-Risk Women.
    Mone F; O'Mahony JF; Tyrrell E; Mulcahy C; McParland P; Breathnach F; Morrison JJ; Higgins J; Daly S; Cotter A; Hunter A; Dicker P; Tully E; Malone FD; Normand C; McAuliffe FM
    Hypertension; 2018 Dec; 72(6):1391-1396. PubMed ID: 30571234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of screening for oral cancer in primary care.
    Speight PM; Palmer S; Moles DR; Downer MC; Smith DH; Henriksson M; Augustovski F
    Health Technol Assess; 2006 Apr; 10(14):1-144, iii-iv. PubMed ID: 16707071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany.
    Schlembach D; Hund M; Schroer A; Wolf C
    BMC Health Serv Res; 2018 Aug; 18(1):603. PubMed ID: 30081904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
    Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
    Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of labor at 39 weeks of gestation versus expectant management for low-risk nulliparous women: a cost-effectiveness analysis.
    Hersh AR; Skeith AE; Sargent JA; Caughey AB
    Am J Obstet Gynecol; 2019 Jun; 220(6):590.e1-590.e10. PubMed ID: 30768934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis.
    Devine A; Harvey R; Min AM; Gilder MET; Paw MK; Kang J; Watts I; Hanboonkunupakarn B; Nosten F; McGready R
    BMC Infect Dis; 2017 Aug; 17(1):552. PubMed ID: 28793866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of recurrence risk guided care versus care as usual in women who suffered from early-onset preeclampsia including HELLP syndrome in their previous pregnancy (the PreCare study).
    Delahaije DH; van Kuijk SM; Dirksen CD; Sep SJ; Peeters LL; Spaanderman ME; Bruinse HW; de Wit-Zuurendonk LD; van der Post JA; Duvekot JJ; van Eyck J; van Pampus MG; van der Hoeven MA; Smits LJ
    BMC Pregnancy Childbirth; 2010 Oct; 10():60. PubMed ID: 20932350
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.